JP Patent

JP7536721B2 — キナーゼを修飾する１ｈ－ピロロ［２，３－ｂ］ピリジン誘導体の合成

Assigned to Daiichi Sankyo Inc · Expires 2024-08-20 · 2y expired

What this patent protects

Patent listed against pexidartinib-hydrochloride.

Drugs covered by this patent

pexidartinib-hydrochloride (PEXIDARTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: JP7536721B2
Jurisdiction: JP
Classification: —
Expires: 2024-08-20
Drug substance claim: No
Drug product claim: No
Assignee: Daiichi Sankyo Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.